close Icon

Antibody responses to the RTS,S/AS01<sub>E</sub> vaccine and <i>Plasmodium falciparum</i> antigens after a booster dose within the phase 3 trial in Mozambique.

Sanchez L, Vidal M, Jairoce C, Aguilar R, Ubillos I, Cuamba I, Nhabomba AJ, Williams NA, Díez-Padrisa N, Cavanagh D, Angov E, Coppel RL, Gaur D, Beeson JG, Dutta S, Aide P, Campo JJ, Moncunill G, Dobaño C

VIEW FULL ARTICLE
  • Journal NPJ vaccines

  • Published 04 Jun 2020

  • Volume 5

  • Pagination 46

  • DOI 10.1038/s41541-020-0192-7

Abstract

booster dose is different from the primary vaccine immune response and highlights the dynamic changes in subclass antibody patterns upon the vaccine booster and with acquisition of adaptive immunity to malaria.